Gil J. van Lunsen, Director at ARRAY BIOPHARMA INC (ARRY), sold 43,000 shares at $16.76 ($721K) on 2018-03-21, disclosed to the SEC on 2018-03-21.
Open-market sale of $721k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.76 | 21,500 | $360K | 50.0% |
| 2 | $16.76 | 21,500 | $360K | 50.0% |
| Total | $16.76 avg | 43,000 | $721K | 100% |
| Filing → |
| ARRY | SELL | 2018-07-19 | $356K | — | Filing → |
| ARRY | SELL | 2018-06-21 | $820K | — | Filing → |
| ARRY | SELL | 2018-05-17 | $330K | — | Filing → |